Dual Immune Checkpoint Blockade Induces Distinct Systemic and Intratumoral Immune Activation in Recurrent Glioblastoma
收藏官方服务：
资源简介：
TCRb sequencing processed data from a randomized window-of-opportunity trial in patients with surgically resectable recurrent GBM, evaluating dual immune checkpoint blockade targeting PD-1 and CTLA-4 vs anti-PD1 alone or placebo before resection.
提供机构：
Zenodo创建时间：
2026-07-31
